Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2015 Sep 15;25(18):3810-5. doi: 10.1016/j.bmcl.2015.07.080. Epub 2015 Jul 29.

Design, synthesis and RON receptor tyrosine kinase inhibitory activity of new head groups analogs of LCRF-0004.

Author information

1
Laboratoires ChemRF Inc./ChemRF Laboratories Inc., 3194 rue Claude-Jodoin, Montréal, QC H1Y 3M2, Canada.
2
Laboratoires ChemRF Inc./ChemRF Laboratories Inc., 3194 rue Claude-Jodoin, Montréal, QC H1Y 3M2, Canada. Electronic address: stephane.raeppel@gmail.com.

Abstract

New heteroarylcarboxamide head groups substituted with two aromatic rings analogs of thieno[3,2-b]pyridine-based kinase inhibitor LCRF-0004 were designed and synthesized. Potent inhibitors of RON tyrosine kinase with various level of selectivity for c-Met RTK were obtained.

KEYWORDS:

Head group; Molecular docking; Oncology; RON; RON homology model; RTK inhibitors; c-Met

PMID:
26243370
DOI:
10.1016/j.bmcl.2015.07.080
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center